J. S. Pober and G. Tellides, Participation of blood vessel cells in human adaptive immune responses, Trends Immunol, vol.33, p.49, 2012.

X. H. Wei, H. T. Orr, ;. Hla-e, and H. Hla-f, Differential expression of, Hum. Immunol, vol.29, p.131, 1990.

M. Ulbrecht, T. Honka, S. Person, J. P. Johnson, and E. H. Weiss, The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein, J. Immunol, vol.149, p.2945, 1992.

C. Grimsley and C. Ober, Population genetic studies of HLA-E: evidence for selection, Hum. Immunol, vol.52, p.33, 1997.

D. E. Geraghty, M. Stockschleader, A. Ishitani, and J. A. Hansen, Polymorphism at the HLA-E locus predates most HLA-A and -B polymorphism, Hum. Immunol, vol.33, p.174, 1992.

L. Zeng, L. C. Sullivan, J. P. Vivian, N. G. Walpole, C. M. Harpur et al., A structural basis for antigen presentation by the MHC class Ib molecule, Qa-1b, J. Immunol, vol.188, p.302, 2012.

R. K. Strong, M. A. Holmes, P. Li, L. Braun, N. Lee et al., HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities, J. Biol. Chem, vol.278, p.5082, 2003.

R. Tamouza, M. Busson, C. Fortier, I. Diagne, D. Diallo et al., HLA-E ? 0101 allele in homozygous state favors severe bacterial infections in sickle cell anemia, Hum. Immunol, vol.68, p.849, 2007.

X. Zeng, H. Chen, R. Gupta, O. Paz-altschul, A. M. Bowcock et al., Deletion of the activating NKG2C receptor and a functional polymorphism in its ligand HLA-E in psoriasis susceptibility, Exp. Dermatol, vol.22, p.679, 2013.

B. H. Koller, D. E. Geraghty, Y. Shimizu, R. Demars, and H. T. Orr, HLA-E. A novel HLA class I gene expressed in resting T lymphocytes, J. Immunol, vol.141, p.897, 1988.

S. Coupel, A. Moreau, M. Hamidou, V. Horejsi, J. P. Soulillou et al., Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation, Blood, vol.109, p.2806, 2007.

L. Derre, M. Corvaisier, B. Charreau, A. Moreau, E. Godefroy et al., Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells, J. Immunol, vol.177, p.3100, 2006.

M. Mittelbronn, P. Simon, C. Loffler, D. Capper, B. Bunz et al., Elevated HLA-E levels in human glioblastomas but not in grade I to III astrocytomas correlate with infiltrating CD8 + cells, J. Neuroimmunol, vol.189, p.50, 2007.

C. A. O'callaghan, J. Tormo, B. E. Willcox, V. M. Braud, B. K. Jakobsen et al., Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E, Mol. Cell, vol.1, p.531, 1998.

N. Lee, D. R. Goodlett, A. Ishitani, H. Marquardt, and D. E. Geraghty, HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences, J. Immunol, vol.160, p.4951, 1998.

F. Borrego, M. Ulbrecht, E. H. Weiss, J. E. Coligan, and A. G. Brooks, Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis, J. Exp. Med, vol.187, p.813, 1998.

V. M. Braud, D. S. Allan, C. A. O'callaghan, K. Soderstrom, A. Andrea et al., HLA-E binds to natural killer cell receptors CD94/NKG2A B and C, Nature, vol.391, p.795, 1998.

L. C. Sullivan, C. S. Clements, T. Beddoe, D. Johnson, H. L. Hoare et al., The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition, Immunity, vol.27, p.900, 2007.

M. Vales-gomez, H. T. Reyburn, R. A. Erskine, M. Lopez-botet, and J. L. Strominger, Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E, EMBO J, vol.18, p.4250, 1999.

B. K. Kaiser, F. Barahmand-pour, W. Paulsene, S. Medley, D. E. Geraghty et al., Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics, J. Immunol, vol.174, p.2878, 2005.

B. K. Kaiser, J. C. Pizarro, J. Kerns, and R. K. Strong, Structural basis for NKG2A/CD94 recognition of HLA-E, Proc. Natl. Acad. Sci. USA, vol.105, p.6696, 2008.

G. Pietra, C. Romagnani, P. Mazzarino, M. Falco, E. Millo et al., HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8 + cytolytic T lymphocytes, Proc. Natl. Acad. Sci. USA, vol.100, p.10896, 2003.

C. Romagnani, G. Pietra, M. Falco, P. Mazzarino, L. Moretta et al., HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes, Hum. Immunol, vol.65, p.437, 2004.

M. Allard, P. Tonnerre, S. Nedellec, R. Oger, A. Morice et al., HLA-Erestricted cross-recognition of allogeneic endothelial cells by CMV-associated CD8 T cells: a potential risk factor following transplantation, PLoS One, vol.7, p.50951, 2012.

J. Nattermann, H. D. Nischalke, V. Hofmeister, G. Ahlenstiel, H. Zimmermann et al., The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells, Am. J. Pathol, vol.166, p.443, 2005.

D. Schulte, M. Vogel, B. Langhans, B. Kramer, C. Korner et al., The HLA-E(R)/HLA-E(R) genotype affects the natural course of hepatitis C virus (HCV) infection and is associated with HLA-E-restricted recognition of an HCVderived peptide by interferon-gamma-secreting human CD8(+) T cells, J. Infect. Dis, vol.200, p.1397, 2009.

R. Salerno-goncalves, M. Fernandez-vina, D. M. Lewinsohn, and M. B. Sztein,

, + T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine, J. Immunol, vol.173, p.5852, 2004.

A. S. Heinzel, J. E. Grotzke, R. A. Lines, D. A. Lewinsohn, A. L. Mcnabb et al., HLA-E-dependent presentation of Mtb-derived antigen to human CD8
URL : https://hal.archives-ouvertes.fr/hal-00089998

. +-t-cells, J. Exp. Med, vol.196, p.1473, 2002.

S. A. Joosten, K. E. Van-meijgaarden, P. C. Van-weeren, F. Kazi, A. Geluk et al., Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity, PLoS Pathog, vol.6, p.1000782, 2010.

C. Leelayuwat, D. C. Townend, M. A. Degli-esposti, L. J. Abraham, and R. L. Dawkins, A new polymorphic and multicopy MHC gene family related to nonmammalian class I, Immunogenetics, vol.40, p.339, 1994.

S. Bahram, M. Bresnahan, D. E. Geraghty, and T. Spies, A second lineage of mammalian major histocompatibility complex class I genes, Proc. Natl. Acad. Sci. USA, vol.91, p.6259, 1994.

B. Aguado and R. D. Campbell, Characterization of a human MHC class III region gene product with S-thioesterase activity, Biochem. J, vol.341, p.679, 1999.

H. A. Stephens, MICA and MICB genes: can the enigma of their polymorphism be resolved?, Trends Immunol, vol.22, p.378, 2001.

P. Li, S. T. Willie, S. Bauer, D. L. Morris, T. Spies et al., Crystal structure of the MHC class I homolog MIC-A, a gamma delta T cell ligand, Immunity, vol.10, p.577, 1999.

L. R. Vitiani, I. Potolicchio, M. Amato, O. R. Baricordi, and R. Sorrentino, MICA exon 5 microsatellite typing by DNA heteroduplex analysis: a new polymorphism in the transmembrane region, Tissue Antigens, vol.51, p.309, 1998.

N. Mizuki, M. Ota, M. Kimura, S. Ohno, H. Ando et al., Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behcet disease, Proc. Natl. Acad. Sci. USA, vol.94, p.1298, 1997.

S. Schrambach, M. Ardizzone, V. Leymarie, J. Sibilia, and S. Bahram, In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancer, PLoS One, vol.2, p.518, 2007.

N. Stern-ginossar, C. Gur, M. Biton, E. Horwitz, M. Elboim et al., Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D, Nat. Immunol, vol.9, p.1065, 2008.

V. Groh, S. Bahram, S. Bauer, A. Herman, M. Beauchamp et al., Cell stressregulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium, Proc. Natl. Acad. Sci. USA, vol.93, p.12445, 1996.

N. W. Zwirner, M. A. Fernandez-vina, and P. Stastny, MICA, a new polymorphic HLArelated antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes, Immunogenetics, vol.47, p.139, 1998.

H. Suemizu, M. Radosavljevic, M. Kimura, S. Sadahiro, S. Yoshimura et al., A basolateral sorting motif in the MICA cytoplasmic tail, Proc. Natl. Acad. Sci. USA, vol.99, p.2971, 2002.

O. Ashiru, S. Lopez-cobo, L. Fernandez-messina, S. Pontes-quero, R. Pandolfi et al., A GPI anchor explains the unique biological features of the common NKG2D-ligand allele MICA ? 008, Biochem. J, vol.454, p.295, 2013.

P. Tonnerre, N. Gerard, M. Chatelais, C. Poli, S. Allard et al., MICA variant promotes allosensitization after kidney transplantation, J. Am. Soc. Nephrol, vol.24, p.954, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-02165869

P. Li, D. L. Morris, B. E. Willcox, A. Steinle, T. Spies et al., Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA, Nat. Immunol, vol.2, p.443, 2001.

D. H. Raulet, Roles of the NKG2D immunoreceptor and its ligands, Nat. Rev. Immunol, vol.3, p.781, 2003.

S. Bauer, V. Groh, J. Wu, A. Steinle, J. H. Phillips et al., Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA, Science, vol.285, p.727, 1999.

J. Wu, Y. Song, A. B. Bakker, S. Bauer, T. Spies et al., An activating immunoreceptor complex formed by NKG2D and DAP10, Science, vol.285, p.730, 1999.

R. A. Eagle and J. Trowsdale, Promiscuity and the single receptor: NKG2D, Nat. Rev. Immunol, vol.7, p.737, 2007.

V. Groh, R. Rhinehart, J. Randolph-habecker, M. S. Topp, S. R. Riddell et al., Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells, Nat. Immunol, vol.2, p.255, 2001.

L. I. Ehrlich, K. Ogasawara, J. A. Hamerman, R. Takaki, A. Zingoni et al., Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8

. +-t-cells, J. Immunol, vol.174, p.1922, 2005.

V. Groh, R. Rhinehart, H. Secrist, S. Bauer, K. H. Grabstein et al., Broad tumorassociated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB, Proc. Natl. Acad. Sci. USA, vol.96, p.6879, 1999.

J. Zhao, J. Huang, H. Chen, L. Cui, and W. He, Vdelta1 T cell receptor binds specifically to MHC I chain related A: molecular and biochemical evidences, Biochem. Biophys. Res. Commun, vol.339, p.232, 2006.

B. Saposnik, J. L. Reny, P. Gaussem, J. Emmerich, M. Aiach et al., A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis, Blood, vol.103, p.1311, 2004.

S. Uitte-de-willige, V. Van-marion, F. R. Rosendaal, H. L. Vos, M. C. Visser et al., Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis, J. Thromb. Haemost, vol.2, p.1305, 2004.

K. Fukudome and C. T. Esmon, Molecular cloning and expression of murine and bovine endothelial cell protein C/activated protein C receptor (EPCR). The structural and functional conservation in human, bovine, and murine EPCR, J. Biol. Chem, vol.270, p.5571, 1995.

S. Kurosawa, D. J. Stearns-kurosawa, N. Hidari, and C. T. Esmon, Identification of functional endothelial protein C receptor in human plasma, J. Clin. Invest, vol.100, p.411, 1997.

K. Fukudome and C. T. Esmon, Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor, J. Biol. Chem, vol.269, p.26486, 1994.

R. E. Simmonds and D. A. Lane, Structural and functional implications of the intron/ exon organization of the human endothelial cell protein C/activated protein C receptor (EPCR) gene: comparison with the structure of CD1/major histocompatibility complex alpha1 and alpha2 domains, Blood, vol.94, p.632, 1999.

C. K. Lau, L. Turner, J. S. Jespersen, E. D. Lowe, B. Petersen et al., Structural conservation despite huge sequence diversity allows EPCR binding by the PfEMP1 family implicated in severe childhood malaria, Cell Host Microbe, vol.17, p.118, 2015.

V. Oganesyan, N. Oganesyan, S. Terzyan, D. Qu, Z. Dauter et al., The crystal structure of the endothelial protein C receptor and a bound phospholipid, J. Biol. Chem, vol.277, p.24851, 2002.

Z. Laszik, A. Mitro, F. B. Taylor, G. Ferrell, and C. T. Esmon, Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway, Circulation, vol.96, p.3633, 1997.

L. Galligan, W. Livingstone, Y. Volkov, K. Hokamp, C. Murphy et al., Characterization of protein C receptor expression in monocytes, Br. J. Haematol, vol.115, p.408, 2001.

D. A. Stephenson, L. J. Toltl, S. Beaudin, and P. C. Liaw, Modulation of monocyte function by activated protein C, a natural anticoagulant, J. Immunol, vol.177, p.2115, 2006.

D. H. Sturn, N. C. Kaneider, C. Feistritzer, A. Djanani, K. Fukudome et al., Expression and function of the endothelial protein C receptor in human neutrophils, Blood, vol.102, p.1499, 2003.

E. A. Bouwens, F. Stavenuiter, and L. O. Mosnier, Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway, J. Thromb. Haemost, vol.11, p.242, 2013.

C. T. Esmon, W. Ding, K. Yasuhiro, J. M. Gu, G. Ferrell et al., The protein C pathway: new insights, Thromb. Haemost, vol.78, p.70, 1997.

L. O. Mosnier, B. V. Zlokovic, and J. H. Griffin, The cytoprotective protein C pathway, Blood, vol.109, p.3161, 2007.

B. V. Zlokovic and J. H. Griffin, Cytoprotective protein C pathways and implications for stroke and neurological disorders, Trends Neurosci, vol.34, p.198, 2011.

C. Guitton, A. Cottereau, N. Gerard, T. Quillard, A. Chauveau et al., Protective cross talk between activated protein C and TNF signaling in vascular endothelial cells: implication of EPCR, noncanonical NF-kappaB, and ERK1/2 MAP kinases, Am. J. Physiol. Cell Physiol, vol.300, p.833, 2011.

C. R. Willcox, V. Pitard, S. Netzer, L. Couzi, M. Salim et al., Cytomegalovirus and tumor stress surveillance by binding of a human gammadelta T cell antigen receptor to endothelial protein C receptor, Nat. Immunol, vol.13, p.872, 2012.

L. Couzi, V. Pitard, J. F. Moreau, P. Merville, and J. Dechanet-merville, Direct and indirect effects of cytomegalovirus-induced gammadelta T Cells after kidney transplantation, Front Immunol, vol.6, p.3, 2015.

H. Das, M. Sugita, and M. B. Brenner, Mechanisms of Vdelta1 gammadelta T cell activation by microbial components, J. Immunol, vol.172, p.6578, 2004.

M. Corvaisier, A. Moreau-aubry, E. Diez, J. Bennouna, J. F. Mosnier et al., V gamma 9V delta 2 T cell response to colon carcinoma cells, J. Immunol, vol.175, p.5481, 2005.

G. Chodaczek, V. Papanna, M. A. Zal, and T. , Body-barrier surveillance by epidermal gammadelta TCRs, Nat. Immunol, vol.13, p.272, 2012.

R. Pacasova, S. Martinozzi, H. J. Boulouis, M. Ulbrecht, J. C. Vieville et al., Cell-surface expression and alloantigenic function of a human nonclassical class I molecule (HLA-E) in transgenic mice, J. Immunol, vol.162, p.5190, 1999.

R. Tamouza, M. Busson, V. Rocha, C. Fortier, Y. Haddad et al., Homozygous status for HLA-E ? 0103 confers protection from acute graftversus-host disease and transplant-related mortality in HLA-matched sibling hematopoietic stem cell transplantation, Transplantation, vol.82, p.1436, 2006.

M. H. Ravindranath, T. Pham, M. Ozawa, and P. I. Terasaki, Antibodies to HLA-E may account for the non-donor-specific anti-HLA class-Ia antibodies in renal and liver transplant recipients, Int. Immunol, vol.24, p.43, 2012.

M. Allard, R. Oger, V. Vignard, J. M. Percier, G. Fregni et al., Serum soluble HLA-E in melanoma: a new potential immune-related marker in cancer, PLoS One, vol.6, p.21118, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-01234644

K. G. Hankey, C. B. Drachenberg, J. C. Papadimitriou, D. K. Klassen, B. Philosophe et al., MIC expression in renal and pancreatic allografts, vol.73, p.304, 2002.

S. Sumitran-holgersson, H. E. Wilczek, J. Holgersson, and K. Soderstrom, Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts, Transplantation, vol.74, p.268, 2002.

Y. Zou, P. Stastny, C. Susal, B. Dohler, and G. Opelz, Antibodies against MICA antigens and kidney-transplant rejection, N. Engl. J. Med, vol.357, p.1293, 2007.

Y. Zou and P. Stastny, Role of MICA in the immune response to transplants, Tissue Antigens, vol.76, p.171, 2010.

B. Suarez-alvarez, A. Lopez-vazquez, R. Diaz-pena, B. Diaz-molina, R. M. Blanco-garcia et al., Post-transplant soluble MICA and MICA antibodies predict subsequent heart graft outcome, Transpl. Immunol, vol.17, p.43, 2006.

D. A. Witherden and W. L. Havran, EPCR: a stress trigger for gammadelta T cells, Nat. Immunol, vol.13, p.812, 2012.

C. Guitton, N. Gerard, V. Sebille, C. Bretonniere, O. Zambon et al., Early rise in circulating endothelial protein C receptor correlates with poor outcome in severe sepsis, Intensive Care Med, vol.37, p.950, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00582321

J. E. Petersen, E. A. Bouwens, I. Tamayo, L. Turner, C. W. Wang et al., Protein C system defects inflicted by the malaria parasite protein PfEMP1 can be overcome by a soluble EPCR variant, Thromb. Haemost, vol.114, 2015.

W. C. Aird, Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms, Circ. Res, vol.100, p.158, 2007.